Non-coding RNAs and Human Diseases: Current Status and Future Perspectives—2nd Edition
A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Biology".
Deadline for manuscript submissions: 30 July 2024 | Viewed by 3269
Special Issue Editors
Interests: heart failure; angiogenesis; miRNA; metabolic syndrome; endothelial cell; macrophage; exosomes
Special Issues, Collections and Topics in MDPI journals
Interests: heart failure; angiogenesis; lymphangiogenesis; metabolic syndrome; endothelial cell; cardiac fibrosis; reproduction biology; electron microscopy
Special Issues, Collections and Topics in MDPI journals
Interests: molecular biology; epigenetics leukemia; endometriosis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Non-coding RNAs (ncRNAs) are RNA molecules that do not serve as templates for protein synthesis but perform housekeeping or regulatory functions. Regulatory ncRNAs as of late have been gaining interest since there is increasing scientific evidence that shows their involvement in many cellular processes, such as proliferation, apoptosis and differentiation. According to the number of nucleotides, regulatory ncRNAs can be divided into main two groups—microRNAs (miRNA) and long non-coding RNAs (lncRNAs). The function of miRNAs is better recognized: they mostly negatively regulate gene expression via translational inhibition or mRNA decay. lncRNAs actions are more complex and less described. There is growing evidence that miRNAs and lncRNAs can interact to regulate gene expression.
Since they can be released into extracellular space and bloodstream, non-coding regulatory transcripts can serve as diagnostic and prognostic markers. Moreover, regulatory ncRNAs are considered therapeutic targets for the treatment of various human diseases. In order to design the most effective diagnostic tools and treatments, it is crucial to understand complicated interactions between regulatory ncRNAs and their impact on cellular mechanisms. The focus of this Special Issue is to underline the most recent discoveries in the field of ncRNA biology. Up-to-date review articles and experimental papers are welcome.
More published papers can be found in the closed Special Issue of our first edition: "Non-coding RNAs and Human Diseases: Current Status and Future Perspectives".
Dr. Justyna Niderla-Bielińska
Dr. Ewa Jankowska-Steifer
Prof. Dr. Paweł Włodarski
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- miRNA
- human disease
- lncRNA
- targeted therapy
- diagnostic biomarkers
- cell physiology
- gene silencing
- epigenetic regulation
- cancer exosomes